CLINICAL_TRIALS trial_result · 2021-07-19

Clinical Trial Update: Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease [Phase 3]

Phase 3 trial update on finerenone for type 2 diabetes with diabetic kidney disease reports efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Bayer | Conditions: Chronic Kidney Disease | Phase 3 | Status: COMPLETED | Results posted: 2021-07-19